Financial News
Nls Pharmaceutics Ltd (NQ: NLSP )
0.1902
+0.0033
(+1.77%)
Streaming Delayed Price
Updated: 3:41 PM EDT, Jun 21, 2024
Add to My Watchlist
All News about Nls Pharmaceutics Ltd
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
NLS Pharmaceutics Announces Patent Issuance in the United States for its Mazindol Extended-Release Formulation
January 04, 2022
From NLS Pharmaceutics AG
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_524.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_342.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_70.jpg)
40 Stocks Moving In Thursday's Mid-Day Session
December 02, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_503.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_69.jpg)
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_501.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
NLS Pharmaceutics CEO Issues Letter to Shareholders
November 01, 2021
From NLS Pharmaceutics AG
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pexels-mart-production-7088489.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/16344.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_1.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_271.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_431.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1547.png)
NLS Pharma Stock Gains After Issuance Of Mazindol Patent
August 19, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1056.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png)
From NLS Pharmaceutics AG
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.